Skip to main content
logo
Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 16, 2026

Nutra Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1110115
Market Cap Growth
0.85%0%9949.17%-99.07%-94.81%106.12%
Enterprise Value
131098923
Last Close Price
0.000.000.000.000.000.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----0.09-
PS Ratio
2.771.841.810.011.73149.92
PB Ratio
--0.04-0.050.00-0.06-0.70

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
50.4427.0122.4913.6420.23238.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.58-0.67-0.67-0.68-0.69-0.40
Net Debt / Equity Ratio
-0.58-0.67-0.67-0.67-0.69-0.40
Net Debt / EBITDA Ratio
-7.58-7.80-11.38-10.67-4.54-4.19
Net Debt / FCF Ratio
-11.75-9.51-23.37-16.86-10.42-4.66
Asset Turnover
0.350.650.630.850.570.18
Inventory Turnover
6.8010.147.789.146.864.88
Quick Ratio
0.010.010.010.010.000.01
Current Ratio
0.020.030.030.020.030.03
Return on Assets (ROA)
-138.06%-154.38%-88.56%-79.46%-155.33%-229.76%
Return on Capital Employed (ROCE)
7.80%8.80%6.00%6.60%16.00%9.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-757.08%-288.38%-181.09%-19721.95%1076.35%-89.38%
FCF Yield
-146.60%-167.61%-59.71%-7785.36%-107.99%-12.17%
Buyback Yield / Dilution
-3.11%-1.37%-0.87%60.16%-164.03%-9.46%